These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15288173)

  • 1. Contrast agent nephropathy.
    Nicol P; Axelson C
    Eur Heart J; 2004 Aug; 25(15):1369; discussion 1369-70. PubMed ID: 15288173
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
    Billinger M; Hess OM; Meier B
    Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
    [No Abstract]   [Full Text] [Related]  

  • 3. N-acetylcysteine and/or theophylline as a preventive measure for contrast agent induced nephropathy: we should use better markers for detection of renal function.
    Schultz MJ
    Radiology; 2007 Dec; 245(3):918-9; author reply 918-9. PubMed ID: 18024462
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The third strike.
    Brinker JA
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):284-5. PubMed ID: 12410498
    [No Abstract]   [Full Text] [Related]  

  • 7. Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?
    Ma IW; Hladunewich M
    CMAJ; 2004 Apr; 170(8):1231. PubMed ID: 15078844
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast nephropathy after coronary angiography.
    Gami AS; Garovic VD
    Mayo Clin Proc; 2004 Feb; 79(2):211-9. PubMed ID: 14959916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
    Rizzato G
    Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
    [No Abstract]   [Full Text] [Related]  

  • 10. N-acetylcysteine in the prevention of contrast-induced nephropathy.
    Fishbane S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contrast-induced nephropathy].
    Westenfeld R; Rump LC
    Dtsch Med Wochenschr; 2013 Apr; 138(14):715-8. PubMed ID: 23533037
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylcysteine for radiocontrast nephropathy.
    Tepel M; Zidek W
    Curr Opin Crit Care; 2001 Dec; 7(6):390-2. PubMed ID: 11805540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of an algorithm to prevent acute kidney injury.
    Dauerman HL
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
    Safirstein R; Andrade L; Vieira JM
    N Engl J Med; 2000 Jul; 343(3):210-2. PubMed ID: 10900284
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of contrast-induced nephropathy and current use of N-acetylcysteine (NAC).
    Anwar M; Ledger S
    CANNT J; 2005; 15(1):33-8,quiz 38-9. PubMed ID: 15909775
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing contrast medium-induced nephropathy.
    Kohtz C; Thompson M
    Am J Nurs; 2007 Sep; 107(9):40-9; quiz 49-50. PubMed ID: 17721148
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of acetylcysteine for preventing contrast-induced nephropathy].
    Schaad N; Barghouth G
    Rev Med Suisse; 2005 Jun; 1(25):1693-6. PubMed ID: 16117036
    [No Abstract]   [Full Text] [Related]  

  • 18. N-acetylcysteine and contrast-induced nephropathy.
    Wolak A; Cafri C; Zahger D
    N Engl J Med; 2006 Oct; 355(14):1498; author reply 1499-500. PubMed ID: 17024739
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.
    Bouzas-Mosquera A; Vázquez-Rodríguez JM
    Am J Cardiol; 2008 Mar; 101(6):910. PubMed ID: 18328863
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigating the volume status before contrast nephropathy studies.
    Toprak O; Cirit M
    Nephrol Dial Transplant; 2005 Feb; 20(2):464; author reply 464-6. PubMed ID: 15673702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.